跳至主要内容
临床试验/NCT01963338
NCT01963338已完成不适用

A Randomized Controlled Study to Assess the Acceptability and Usability of New Delivery Device for Intradermal Vaccination in Healthy Volunteers

Pierre Van Damme1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
1
主要终点
Adverse events after an injection with an intradermal delivery device and/or intramuscular injection with syringe and needle

研究概览

简要总结

The aim of this study was to assess the acceptability and usability of a newly developed intradermal device in healthy adults

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy adults

排除标准

  • people who have regular experience with needle injections, e.g. diabetic patients
  • pregnant women

研究组 & 干预措施

Intradermal group

Experimental

These group participants received two intradermal injections with the newly developed device, one in the forearm and one in the upper arm (deltoid region).

干预措施: Intradermal injection in the forearm (0,1cc NaCl 0,9%) (Device)

Intradermal group

Experimental

These group participants received two intradermal injections with the newly developed device, one in the forearm and one in the upper arm (deltoid region).

干预措施: Intradermal injection in the upper arm (0,1cc NaCl 0,9%) (Device)

Intramuscular group

Experimental

These group participants received one intramuscular injection in the upper arm(deltoid region) using needle and syringe and one intradermal injection in the forearm using the newly developed device.

干预措施: Intradermal injection in the forearm (0,1cc NaCl 0,9%) (Device)

Intramuscular group

Experimental

These group participants received one intramuscular injection in the upper arm(deltoid region) using needle and syringe and one intradermal injection in the forearm using the newly developed device.

干预措施: Intramuscular injection in the upper arm (0,5cc NaCl 0,9%) (Drug)

结局指标

主要结局

Adverse events after an injection with an intradermal delivery device and/or intramuscular injection with syringe and needle

时间窗: during 5 days after the injections

Volunteers were asked to fill a daily electronic diary for 5 days after the injections. The diary surveyed the presence of local reactions (pain at injection site, redness, swelling, ecchymosis and hardening) and systemic adverse events (headache, malaise, chills, myalgia, arthralgia, weakness/fatigue and temperature). In case of local reactions, participants were asked to measure the size of the reaction (in mm). For this purpose, a transparent ruler was provided to the participants at the study day.

Acceptability (e.g. pain) of an injection with an intradermal vaccine delivery device compared to an intramuscular injection with syringe and needle

时间窗: 1 day (directly after the injections)

Each of the volunteers was asked to complete two questionnaires: first questionnaire surveyed demographic parameters, including gender, age, health care related job or education, number of vaccinations and blood samples taken during the last 5 years, second questionnaire surveyed the experience of ID and/or IM injection, such as anxiety, pain during injection and duration of injection. Also the perception of the participant towards injections into the forearm, which could be perceived as an unnatural site for vaccination, and perception towards the need to undress for IM vaccination, i.e. preparing the upper arm for injection, was asked. The Visual Analogue Scale (1=no agreement; 10=full agreement) was used to score the statements.

次要结局

  • Usability (e.g. handling) of an injection with an intradermal vaccine delivery device compared to an intramuscular injection with syringe and needle(Within one day after administering the injections)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Pierre Van Damme

Professor

Universiteit Antwerpen

研究点 (1)

Loading locations...

相似试验